[1]
Mạnh, P.D., Toàn, P.K. and Huy, T.L. 2025. 82. Gefitinib rechallenge After Osimertinib-Induced Interstitial Lung Disease: A Case Report and Literature Review. Journal of Medical Research. 195, 10 (Oct. 2025), 795-800. DOI:https://doi.org/10.52852/tcncyh.v195i10.3929.